Short description
TetraLogic Pharmaceuticals discovers and develops small molecule drugs for the treatment of debilitating diseases and conditions.
Description
TetraLogic Pharmaceuticals is a privately held biopharmaceutical company that discovers and develops small molecule drugs that modulate programmed cell death pathways to treat debilitating diseases and conditions. The company's Smac Mimetics neutralize critical blocks in the apoptosis pathway to selectively destroy cancer cells. Its Necrostatin drugs block critical steps in the process leading to necrosis, enabling cell survival in a wide range of diseases and injuries where necrosis is a critical component of pathology.
Last funding
Noaccess
Sign in for full access
Total funding
$$121212
Sign in for full access
Location
Malvern, Pennsylvania, United States, North America
Founded on
January 1, 2001
Exited on
November 3, 2016
Went public on
November 3, 2016
Stock symbol
TLOG
Non-profit?
No
Acquired?
No
Employees count
11-50
Revenue range
$56378 - 90123
Sign in for full access
Investors
Blurry Noaccess, Noway Youcantaccess, Noway Youcantaccess, Noaccessforu, Noaccessforu, Nopepepe, Noaccess, Noaccessforu, Uh Ohhhh, Uh Ohhhh, Noaccessforu, No Way, Cannot Access
Sign in for full access
Founders
John M. Gill